Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Almirall On Alert As Lebrikizumab Approval Date Approaches

As Dermatology Sales Climb In Q1

May 09 2023

• By Kevin Grogan

Almirall — • Source: Almirall

Related Content

EMA Recommends New Measures For JAK Inhibitors After Confirming Serious Risks

Oct 28 2022

Galderma Readies Its First Therapeutic Biologic For Two US Launches In 2024

Mar 14 2023

Sanofi And Amgen Make The Case For OX40 Drugs In Atopic Dermatitis

Oct 04 2021

Related Companies

Almirall SA

Eli Lilly and Company

Sanofi

Regeneron Pharmaceuticals, Inc.

Incyte Corporation

Pfizer Inc.

Galderma S.A.

Kyowa Kirin Co., Ltd.

MC2 Therapeutics A/S

Additional Topics

Sales & Earnings Business Strategies Clinical Trials Commercial Dermatology BioPharmaceutical

More from Earnings

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window